Search

everythinglearnresearchcommunity

for

Search:↓

Patients with alopecia areata face challenges accessing Janus kinase inhibitors, but some see positive results.

Deleting Snai2 and Snai3 causes fatal autoimmunity.

CD80CD86 deficiency causes hair loss by disrupting regulatory T cells.

Neurogenic inflammation may play a role in hair loss in alopecia areata.

Baricitinib helped treat a man's beard hair loss when steroids didn't work.

Alopecia areata severity is linked to increased TH1 and TH2 activity.

Alopecia areata involves immune system imbalances that may lead to depression and anxiety.

Mice genetically modified to produce more CD109 in their skin had less inflammation and better healing with less scarring.

A PTH-based treatment improved hair regrowth better than ruxolitinib in a mouse model of hair loss.

The role of γδT-cells in causing alopecia areata remains unclear.

Memory regulatory T cells need IL-7, not IL-2, to stay in peripheral tissues.

Piperonylic acid speeds up wound healing by reducing inflammation and boosting collagen.

Tofacitinib was more effective than apremilast in treating hair loss in a mouse model of alopecia areata.

Rapamycin treatment helps reduce brain inflammation and symptoms of mitochondrial disease by blocking specific pathways in mice.

JAK inhibitors effectively treat severe alopecia areata with manageable side effects.

The immune system plays a key role in tissue repair, affecting both healing quality and regenerative ability.

Adjusting the medication tacrolimus resolved a boy's red nail beds after a stem cell transplant.

Diagnosing and treating rapidly worsening lung disease is difficult and requires better guidelines and understanding.

T-cells in alopecia areata scalp show abnormal regulation, leading to less inflammation.

Removing Gsdma1/2/3 genes reduces skin cell overgrowth by blocking a specific cell pathway.

Targeting mTOR in myeloid cells may help reduce psoriasis symptoms.

JAK inhibitors are effective for hair regrowth in severe alopecia areata.

Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.

Understanding molecular mediators can improve skin healing treatments.

Patients with Systemic Sclerosis have much higher levels of GDF-15, which could help predict organ involvement and guide treatment.

Plakophilin 1 helps control skin cell immune responses to prevent excessive inflammation.

The CD44-CD49d complex boosts T cell activation and survival in autoimmune disease.

Some patients receiving pegylated interferon alfa injections developed skin necrosis, requiring treatment adjustments or discontinuation.